Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiaoruisu capsules post-marketing safety monitoring in patients with phlegm-heat syndrome (cough, sputum, wheezing)
CTR20250703Phase 4Active
- Sponsor
- Hubei Furen Pharmaceutical
- Start
- Feb 2025
- Countries
- 1
01
Overview
A Phase 4 trial of Qiaoruisu capsules in cough, acute bronchitis, chronic bronchitis (CB), Airways Infection, sponsored by Hubei Furen Pharmaceutical. Started Feb 2025; status: active.
02
Drugs
Qiaoruisu capsules
03
Conditions
coughacute bronchitischronic bronchitis (CB)Airways Infection
Beyond the preview
Go deeper on CTR20250703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250703.